Anthropic’s Mythos is evolving faster than expected, reports AI safety agency – ZDNET
Follow ZDNET: Add us as a preferred source
Similar Posts
Will he stay or will he go? Powell is not saying whether he’ll stay on Fed board when chair term ends – CNBC
It’s one of the most important questions surrounding the Federal Reserve in 2026, and Fed Chair Jerome Powell has been pointedly mum. “I’m focused on my remaining time as chair,” Powell said at the December press conference. “I haven’t got anything new on that to tell you.” The question: whether Powell will remain on the…
NASA Wants to Put Nuclear Reactors on the Moon – WIRED
Having demonstrated that it has the operational capability to transport humans safely to the moon and back, the United States is moving on to its next major aim: It wants nuclear reactors in orbit and on the lunar surface by 2030. For such a feat, the National Aeronautics and Space Administration will have to work…
NFL adds Kraft Heinz as its first-ever condiment partner – NBC Sports
Nearly four years ago, the Heinz name and oversized ketchup bottles exited the stadium where the Steelers play. Heinz is now back in the NFL business, in a big way. The NFL announced on Wednesday morning that Kraft Heinz is the league’s “first-ever global condiment partner.” The partnership officially begins with the 2026 NFL draft….
A Once-in-a-Decade Investment Opportunity: The Best Artificial Intelligence (AI) Stock to Buy in 2026 – The Motley Fool
Nvidia has been the star of the artificial intelligence show for three years, and its stellar performance doesn’t appear to be coming to an end. For the last three years, the stock market’s biggest tailwinds have stemmed from virtually anything that touches artificial intelligence (AI). Within the AI landscape, semiconductor giant Nvidia (NVDA +0.00%) has…
FDA rejects Regenxbio’s rare-disease gene therapy – statnews.com
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. The Food and Drug Administration…
OpenAI’s 2026 ‘focus’ is ‘practical adoption’ – The Verge
As the company spends a huge amount of money on infrastructure, OpenAI is working to close the gap on what AI can do and how people actually use it. As the company spends a huge amount of money on infrastructure, OpenAI is working to close the gap on what AI can do and how people…
